Accurate Detection and Quantitation of Heteroplasmic Mitochondrial Point Mutations by Pyrosequencing
- 1 September 2005
- journal article
- research article
- Published by Mary Ann Liebert Inc in Genetic Testing
- Vol. 9 (3) , 190-199
- https://doi.org/10.1089/gte.2005.9.190
Abstract
Disease-causing mutations in mitochondrial DNA (mtDNA) are typically heteroplasmic and therefore interpretation of genetic tests for mitochondrial disorders can be problematic. Detection of low level heteroplasmy is technically demanding and it is often difficult to discriminate between the absence of a mutation or the failure of a technique to detect the mutation in a particular tissue. The reliable measurement of heteroplasmy in different tissues may help identify individuals who are at risk of developing specific complications and allow improved prognostic advice for patients and family members. We have evaluated Pyrosequencing technology for the detection and estimation of heteroplasmy for six mitochondrial point mutations associated with the following diseases: Leber's hereditary optical neuropathy (LHON), G3460A, G11778A, and T14484C; mitochondrial encephalopathy with lactic acidosis and stroke-like episodes (MELAS), A3243G; myoclonus epilepsy with ragged red fibers (MERRF), A8344G, and neurogenic muscle weakness, ataxia, and retinitis pigmentosa (NARP)/Leighs: T8993G/C. Results obtained from the Pyrosequencing assays for 50 patients with presumptive mitochondrial disease were compared to those obtained using the commonly used diagnostic technique of polymerase chain reaction (PCR) and restriction enzyme digestion. The Pyrosequencing assays provided accurate genotyping and quantitative determination of mutational load with a sensitivity and specificity of 100%. The MELAS A3243G mutation was detected reliably at a level of 1% heteroplasmy. We conclude that Pyrosequencing is a rapid and robust method for detecting heteroplasmic mitochondrial point mutations.Keywords
This publication has 32 references indexed in Scilit:
- High-Sensitivity Detection of the A3243G Mutation of Mitochondrial DNA by a Combination of Allele-Specific PCR and Peptide Nucleic Acid-Directed PCR ClampingClinical Chemistry, 2004
- Quantification of Mitochondrial DNA Heteroplasmy by Temporal Temperature Gradient Gel ElectrophoresisClinical Chemistry, 2003
- Heteroplasmy of the Human mtDNA Control Region Remains Constant during LifeAmerican Journal of Human Genetics, 2001
- A Sensitive Denaturing Gradient-Gel Electrophoresis Assay Reveals a High Frequency of Heteroplasmy in Hypervariable Region 1 of the Human mtDNA Control Region**Disclaimer: The opinions and assertions expressed herein are solely those of the authors and are not to be construed as official or the views of the United States Department of Defense, the United States Department of the Army, or the United States Department of Commerce. This paper is a contribution of the United States National Institute of Standards and Technology (NIST) and the United States Department of Defense and is not subject to copyright. Certain commercial equipment, instruments, or companies are identified in this paper to specify the experimental procedure. Such identification does not imply recommendation or endorsement by the government, nor does it imply that the materials or equipment identified are the best available for this purpose.American Journal of Human Genetics, 2000
- A false-positive diagnosis for the common MELAS (A3243G) mutation caused by a novel variant (A3426G) in the ND1 gene of mitochondria DNAMolecular Diagnosis, 1998
- A Sequencing Method Based on Real-Time PyrophosphateScience, 1998
- Novel mitochondrial DNA variant that may give a false positive diagnosis for the T8993C mutationMolecular Diagnosis, 1998
- Quantitation of heteroplasmy of mitochondrial trnaLeu(UUR) gene using PCR‐SSCPMuscle & Nerve, 1995
- An ND-6 mitochondrial DNA mutation associated with leber hereditary optic neuropathyBiochemical and Biophysical Research Communications, 1992
- Mitochondrial DNA Mutation Associated with Leber's Hereditary Optic NeuropathyScience, 1988